ArticleThe Analyst2016
Development of an integrated microfluidic solid-phase extraction and electrophoresis device.
Article in The Analyst, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 29 citations in OpenAlex.
- 3D printed microfluidic devices for integrated solid-phase extraction and microchip electrophoresis of preterm birth biomarkers.Analytica chimica acta · 2024Article
- Faster, better, and cheaper: harnessing microfluidics and mass spectrometry for biotechnology.RSC chemical biology · 2021Review
- 3D Printed Microfluidic Devices for Solid-Phase Extraction and On-Chip Fluorescent Labeling of Preterm Birth Risk Biomarkers.Analytical chemistry · 2020Article
- Microchip electrophoresis separation of a panel of preterm birth biomarkers.Electrophoresis · 2018Article
- Automated microfluidic devices integrating solid-phase extraction, fluorescent labeling, and microchip electrophoresis for preterm birth biomarker analysis.Analytical and bioanalytical chemistry · 2018Article
- Electrokinetically operated microfluidic devices for integrated immunoaffinity monolith extraction and electrophoretic separation of preterm birth biomarkers.The Analyst · 2017Article
- Recent advances in microfluidic sample preparation and separation techniques for molecular biomarker analysis: A critical review.Analytica chimica acta · 2017Review
- Integrated electrokinetically driven microfluidic devices with pH-mediated solid-phase extraction coupled to microchip electrophoresis for preterm birth biomarkers.Electrophoresis · 2017Article
- Review
- Monitoring cell secretions on microfluidic chips using solid-phase extraction with mass spectrometry.Analytical and bioanalytical chemistry · 2017Article
- On-Chip Fluorescent Labeling using Reversed-phase Monoliths and Microchip Electrophoretic Separations of Selected Preterm Birth Biomarkers.Analytical methods : advancing methods and applications · 2016Article
- Advances in monoliths and related porous materials for microfluidics.Biomicrofluidics · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
This study focuses on the design and fabrication of a microfluidic platform that integrates solid-phase extraction (SPE) and microchip electrophoresis (μCE) on a single device. The integrated chip is a multi-layer structure consisting of polydimethylsiloxane valves with a peristaltic pump, and a porous polymer monolith in a thermoplastic layer. The valves and pump are fabricated using soft lithography to enable pressure-based fluid actuation. A porous polymer monolith column is synthesized in the SPE unit using UV photopolymerization of a mixture consisting of monomer, cross-linker, photoinitiator, and porogens. The hydrophobic, porous structure of the monolith allows protein retention with good through flow. The functionality of the integrated device in terms of pressure-controlled flow, protein retention and elution, on-chip enrichment, and separation is evaluated using ferritin (Fer). Fluorescently labeled Fer is enriched ∼80-fold on a reversed-phase monolith from an initial concentration of 100 nM. A five-valve peristaltic pump produces higher flow rates and a narrower Fer elution peak than a three-valve pump operated under similar conditions. Moreover, the preconcentration capability of the SPE unit is demonstrated through μCE of enriched Fer and two model peptides in the integrated system. FA, GGYR, and Fer are concentrated 4-, 12-, and 50-fold, respectively. The loading capacity of the polymer monolith is 56 fmol (25 ng) for Fer. This device lays the foundation for integrated systems that can be used to analyze various disease biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.